PACK-CXL: Clinical Trials

2 trials of PACK-CXL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 31Completed 1

Follow PACK-CXL: new trials by email Literature Review of PACK-CXL trials Research Report on PACK-CXL

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cross-linking as Treatment in Infectious Keratitis
PACK-CXL - Infectious Keratitis
Not applicableCompletedSohag University372020-06-022023-01-18
Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis
PACK-CXL, Cefazolin in combination with either tobramycin or gentamicin, Cycloplegic agents (cyclopentolate 1% eye drops) - Keratitis; Infectious Disease (Manifestation)
Phase 3CompletedUniversity Hospital, Geneva352016-03-012020-10-20

Conditions studied

Communicable Diseases (1)  ·  Keratitis (1)

Sponsors

Sohag University (1)  ·  University Hospital, Geneva (1)

Countries

Egypt (1)  ·  Switzerland (1)

Top investigators

Farhad Hafezi, MD, PhD (1)  ·  Mohammed Iqbal, MD. PhP (1)

Results publications

PMID 32557558, PMID 34996516